← Leaderboards
Gregory Thomas Collins
South Texas Veterans Health Care System
$4,329,392
Attributed
$5,108,261
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $768.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,108,261 · 3
VA$0 · 1
By mechanism
R01$3,451,116 · 1
U01$1,557,738 · 1
F31$99,407 · 1
I01$0 · 1
Top collaborators
- Charles P France4 shared
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseSelf AdministrationPharmaceutical PreparationsProceduresEffectivenessAcuteRecording Of Previous EventsRattusInnovationCocaineEffective TherapyCardiovascular SystemToxic EffectBehaviorFemaleHeart RatePublic HealthMaleDopamineBaseReinforcement ScheduleSerotoninAbstinenceLaboratories
Grant awards (21)
Bath Salts: abuse-related and toxic effects$360,105
R01 · FY2024 · DA · contact PI
Bath Salts: abuse-related and toxic effects$360,105
R01 · FY2023 · DA · contact PI
Preclinical Psychopharmacology of Substance Abuse$0
I01 · FY2023 · VA · contact PI
Bath Salts: abuse-related and toxic effects$360,105
R01 · FY2022 · DA · contact PI
Preclinical Psychopharmacology of Substance Abuse$0
I01 · FY2022 · VA · contact PI
Repurposing drugs in mixtures to treat drug abuse$361,736
U01 · FY2021 · DA
Bath Salts: abuse-related and toxic effects$359,175
R01 · FY2021 · DA · contact PI
Preclinical Psychopharmacology of Substance Abuse$0
I01 · FY2021 · VA · contact PI
Repurposing drugs in mixtures to treat drug abuse$361,736
U01 · FY2020 · DA
Bath Salts: abuse-related and toxic effects$332,226
R01 · FY2020 · DA · contact PI
Preclinical Psychopharmacology of Substance Abuse$0
I01 · FY2020 · VA · contact PI
Repurposing drugs in mixtures to treat drug abuse$409,094
U01 · FY2019 · DA
Bath salts: abuse-related and toxic effects$343,125
R01 · FY2019 · DA · contact PI
Repurposing drugs in mixtures to treat drug abuse$425,172
U01 · FY2018 · DA
Bath salts: abuse-related and toxic effects$343,125
R01 · FY2018 · DA · contact PI
Bath salts: abuse-related and toxic effects$343,125
R01 · FY2017 · DA · contact PI
Bath salts: abuse-related and toxic effects$339,693
R01 · FY2016 · DA · contact PI
Bath salts: abuse-related and toxic effects$310,332
R01 · FY2015 · DA · contact PI
in vivo characterization of D2/D3 agonists & antagonists$33,080
F31 · FY2007 · DA · contact PI
in vivo characterization of D2/D3 agonists & antagonists$32,686
F31 · FY2006 · DA · contact PI
in vivo characterization of D2/D3 agonists &antagonists$33,641
F31 · FY2005 · DA